CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30776% above fair value
$6.82+0.17 (+2.56%)
Close on Nov 18, 2026Market cap $341.32MP/E –Yield –
CapsoVision shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
CapsoVision's shares outstanding was 50M at Jun 30, 2026. For fiscal 2025 it was 25M, up 1115.6% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 25M | +1115.6% |
| FY2024 | Dec 31, 2024 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 50M | +2078.6% |
| Q1 FY2026 | Mar 31, 2026 | 47M | +2099.5% |
| Q4 FY2025 | Dec 31, 2025 | 47M | +2143.1% |
| Q3 FY2025 | Sep 30, 2025 | 46M | +2125.2% |
| Q2 FY2025 | Jun 30, 2025 | 2M | +12.2% |
| Q1 FY2025 | Mar 31, 2025 | 2M | – |
| Q4 FY2024 | Dec 31, 2024 | 2M | – |
| Q3 FY2024 | Sep 30, 2024 | 2M | – |
| Q2 FY2024 | Jun 30, 2024 | 2M | – |
See a number that looks wrong?